111 related articles for article (PubMed ID: 10666001)
1. Supraspinal and spinal effects of [Phe1psi(CH2-NH)Gly2]-nociceptin(1-13)-NH2 on nociception in the rat.
Candeletti S; Guerrini R; Calò G; Romualdi P; Ferri S
Life Sci; 2000; 66(3):257-64. PubMed ID: 10666001
[TBL] [Abstract][Full Text] [Related]
2. [Phe1psi(CH2-NH)Gly2]-nociceptin-(1-13)NH2, a proposed antagonist of the nociceptin receptor, is a potent and stable agonist in the rat spinal cord.
Xu IS; Wiesenfeld-Hallin Z; Xu XJ
Neurosci Lett; 1998 Jun; 249(2-3):127-30. PubMed ID: 9682833
[TBL] [Abstract][Full Text] [Related]
3. Supraspinal hyperalgesia and spinal analgesia by [Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 in rat.
Wang YQ; Zhu CB; Cao XD; Wu GC
Eur J Pharmacol; 1999 Jul; 376(3):R1-3. PubMed ID: 10448896
[TBL] [Abstract][Full Text] [Related]
4. Nociceptin and the ORL-1 ligand [Phe1psi (CH2-NH)Gly2]nociceptin(1-13)NH2 exert anti-opioid effects in the Freund's adjuvant-induced arthritic rat model of chronic pain.
Bertorelli R; Corradini L; Rafiq K; Tupper J; Calò G; Ongini E
Br J Pharmacol; 1999 Nov; 128(6):1252-8. PubMed ID: 10578139
[TBL] [Abstract][Full Text] [Related]
5. Evidence that [Phe1 psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2, a peripheral ORL-1 receptor antagonist, acts as an agonist in the rat spinal cord.
Carpenter KJ; Dickenson AH
Br J Pharmacol; 1998 Nov; 125(5):949-51. PubMed ID: 9846631
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of cardiovascular activity following microinjection of novel opioid-like neuropeptide nociceptin (orphanin FQ) into the rat rostral ventrolateral medulla.
Chu X; Xu N; Li P; Mao L; Wang JQ
Brain Res; 1999 May; 829(1-2):134-42. PubMed ID: 10350539
[TBL] [Abstract][Full Text] [Related]
7. Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor.
Guerrini R; Caló G; Bigoni R; Rizzi A; Varani K; Toth G; Gessi S; Hashiba E; Hashimoto Y; Lambert DG; Borea PA; Tomatis R; Salvadori S; Regoli D
J Med Chem; 2000 Jul; 43(15):2805-13. PubMed ID: 10956188
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the locomotor activity-inhibiting effect of nociceptin/orphanin FQ in mice.
Rizzi A; Bigoni R; Marzola G; Guerrini R; Salvadori S; Regoli D; Calo' G
Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):161-5. PubMed ID: 11218068
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)NH2 in rat brain, rat vas deferens and CHO cells expressing recombinant human nociceptin receptors.
Okawa H; Nicol B; Bigoni R; Hirst RA; Calo G; Guerrini R; Rowbotham DJ; Smart D; McKnight AT; Lambert DG
Br J Pharmacol; 1999 May; 127(1):123-30. PubMed ID: 10369464
[TBL] [Abstract][Full Text] [Related]
10. Effect of nociceptin and [Phe1psi (CH2-NH) Gly2]-nociceptin-(1-13)-NH2 on tonic activity of rat hypothalamic neurons.
Yakimova KS; Pierau FK
Neurosci Lett; 1999 Oct; 274(2):87-90. PubMed ID: 10553944
[TBL] [Abstract][Full Text] [Related]
11. The nociceptin receptor-mediated inhibition of the rat rostral ventrolateral medulla neurons in vitro.
Chu X; Xu N; Li P; Wang JQ
Eur J Pharmacol; 1999 Jan; 364(1):49-53. PubMed ID: 9920184
[TBL] [Abstract][Full Text] [Related]
12. Central administration of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)-NH2 and orphanin FQ/nociceptin (OFQ/N) produce similar cardiovascular and renal responses in conscious rats.
Kapusta DR; Chang JK; Kenigs VA
J Pharmacol Exp Ther; 1999 Apr; 289(1):173-80. PubMed ID: 10087001
[TBL] [Abstract][Full Text] [Related]
13. Role of nociceptin/orphanin FQ and the pseudopeptide [Phe1Psi(CH2NH)Gly2]-nociceptin(1-13)-NH2 and their interaction with classic opioids in the modulation of thermonociception in the land snail Helix aspersa.
Miller-Pérez C; Sánchez-Islas E; Pellicer F; Rodríguez-Manzo G; Cruz SL; León-Olea M
Eur J Pharmacol; 2008 Feb; 581(1-2):77-85. PubMed ID: 18096155
[TBL] [Abstract][Full Text] [Related]
14. [Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 is an agonist of the nociceptin (ORL1) receptor.
Butour JL; Moisand C; Mollereau C; Meunier JC
Eur J Pharmacol; 1998 May; 349(1):R5-6. PubMed ID: 9669489
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay.
Calò G; Rizzi A; Marzola G; Guerrini R; Salvadori S; Beani L; Regoli D; Bianchi C
Br J Pharmacol; 1998 Sep; 125(2):373-8. PubMed ID: 9786511
[TBL] [Abstract][Full Text] [Related]
16. Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies.
Bigoni R; Giuliani S; Calo' G; Rizzi A; Guerrini R; Salvadori S; Regoli D; Maggi CA
Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):160-7. PubMed ID: 10208302
[TBL] [Abstract][Full Text] [Related]
17. [Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 acts as an agonist of the orphanin FQ/nociceptin receptor in vivo.
Grisel JE; Farrier DE; Wilson SG; Mogil JS
Eur J Pharmacol; 1998 Sep; 357(1):R1-3. PubMed ID: 9788779
[TBL] [Abstract][Full Text] [Related]
18. Antinociceptive and morphine modulatory actions of spinal orphanin FQ.
Jhamandas KH; Sutak M; Henderson G
Can J Physiol Pharmacol; 1998 Mar; 76(3):314-24. PubMed ID: 9673795
[TBL] [Abstract][Full Text] [Related]
19. Spinal and local peripheral antiallodynic activity of Ro64-6198 in neuropathic pain in the rat.
Obara I; Przewlocki R; Przewlocka B
Pain; 2005 Jul; 116(1-2):17-25. PubMed ID: 15927383
[TBL] [Abstract][Full Text] [Related]
20. A new selective antagonist of the nociceptin receptor.
Guerrini R; Calo G; Rizzi A; Bigoni R; Bianchi C; Salvadori S; Regoli D
Br J Pharmacol; 1998 Jan; 123(2):163-5. PubMed ID: 9489602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
